^(18)F-FDG显像在管理经治肺癌患者中的作用  

Role of^(18)F-FDG imaging in managing the patients with lung cancer after therapy

作　　者：刘靖[1] 孔令山[1] 崔斌[1] 谢明萱[1] 

机构地区：[1]第二军医大学附属长海医院核医学科,上海200433

出　　处：《中国医学影像技术》2004年第11期1764-1767,共4页Chinese Journal of Medical Imaging Technology

摘　　要：目的　探讨18F FDGPET显像在诊断、治疗经治肺癌患者中的作用。方法　对 92例经治肺癌患者进行18F FDGPET显像及CT检查 ,检查后随访 6～ 48个月 ,将未发生死亡及转移患者的标准摄取值 (SUV)与其余患者相比较 ;分析患者SUV与其生存状况。结果　对于经治肺癌患者 ,18F FDGPET在诊断敏感性、准确性、阴性预测值上均明显优于CT ;未发生死亡及转移患者SUV小于其余患者 ;患者生存状况与其SUV大小具有相关性。结论　18FObjective To investigate the role of^(18)F-FDG PET imaging in the diagnosis and treatment of lung cancer. Methods Whole-body PET and CT were performed in 92 patients with lung cancer after therapy, which were then followed up for 6 to 48 months. The standardized uptake value (SUV) of patients who were alive and had no metastasis was compared with that of the others, and the correlation between SUV and their living conditions were analized. Results The sensitivity, accuracy and negative predictive value of PET were more effective than those of CT. The SUV of patients alive and with no metastasis were lower than the SUV of the others. Significant correlation between SUV and living condition was found in these patients. Conclusion ^(18)F-FDG PET imaging is useful in monitoring the state of patients and drawing the following therapy scheme for treated lung cancer. [

关 键 词：肺肿瘤 诊断 鉴别 体层摄影术 发射型计算机 脱氧葡萄糖 预后 

分 类 号：R817.4[医药卫生—影像医学与核医学] R734.2[医药卫生—放射医学]